Stephen J. Murphy

3.2k total citations
71 papers, 2.1k citations indexed

About

Stephen J. Murphy is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stephen J. Murphy has authored 71 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stephen J. Murphy's work include Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Stephen J. Murphy is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Lung Cancer Treatments and Mutations (10 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Stephen J. Murphy collaborates with scholars based in United States, United Kingdom and Netherlands. Stephen J. Murphy's co-authors include George Vasmatzis, Sarah H. Johnson, Edward B. Leof, Farhad Kosari, Mark C. Wilkes, Benjamin R. Kipp, Dennis A. Wigle, Richard G. Vile, Faye R. Harris and Aaron S. Mansfield and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Stephen J. Murphy

68 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Murphy United States 26 927 806 602 515 384 71 2.1k
Kathleen Cieply United States 30 940 1.0× 857 1.1× 737 1.2× 400 0.8× 695 1.8× 58 2.6k
Douglas I. Lin United States 26 1.4k 1.5× 1.0k 1.3× 916 1.5× 417 0.8× 299 0.8× 112 2.6k
Leah Prentice Canada 18 909 1.0× 552 0.7× 287 0.5× 456 0.9× 220 0.6× 26 2.2k
Mark L. Levitt United States 16 799 0.9× 1.1k 1.4× 464 0.8× 349 0.7× 216 0.6× 43 1.9k
Linda Kapusta Canada 16 902 1.0× 1.1k 1.4× 443 0.7× 409 0.8× 306 0.8× 23 2.1k
Natália Buza United States 33 673 0.7× 1.2k 1.5× 430 0.7× 325 0.6× 349 0.9× 134 2.9k
Nobuyuki Susumu Japan 32 1.1k 1.2× 656 0.8× 294 0.5× 743 1.4× 251 0.7× 140 3.1k
Evgeny Yakirevich United States 28 833 0.9× 846 1.0× 614 1.0× 540 1.0× 493 1.3× 89 2.3k
Hee Jung An South Korea 27 1.3k 1.4× 818 1.0× 382 0.6× 766 1.5× 313 0.8× 76 2.5k
Michael R. Pins United States 26 870 0.9× 660 0.8× 801 1.3× 392 0.8× 729 1.9× 68 2.3k

Countries citing papers authored by Stephen J. Murphy

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Murphy more than expected).

Fields of papers citing papers by Stephen J. Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Murphy. The network helps show where Stephen J. Murphy may publish in the future.

Co-authorship network of co-authors of Stephen J. Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Murphy. A scholar is included among the top collaborators of Stephen J. Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Murphy. Stephen J. Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrett, Michael T., Faye R. Harris, Ryan W. Feathers, et al.. (2021). Combination targeted treatment may enhance antitumor activity in ERBB3 amplified high-grade serous endometrial cancer cells resistant to single agent targeted therapy. Gynecologic Oncology. 162. S114–S115.
3.
Hazim, Antonious, Neil Majithia, Stephen J. Murphy, et al.. (2021). Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas. Cancer Immunology Immunotherapy. 70(9). 2651–2656. 3 indexed citations
4.
Murphy, Stephen J., James B. Smadbeck, Bruce W. Eckloff, et al.. (2020). Chromosomal Junction Detection from Whole-Genome Sequencing on Formalin-Fixed, Paraffin-Embedded Tumors. Journal of Molecular Diagnostics. 23(4). 375–388. 2 indexed citations
5.
Leiting, Jennifer L., Stephen J. Murphy, John R. Bergquist, et al.. (2020). Biliary tract cancer patient-derived xenografts: Surgeon impact on individualized medicine. JHEP Reports. 2(2). 100068–100068. 17 indexed citations
6.
Vasmatzis, George, Farhad Kosari, Stephen J. Murphy, et al.. (2019). Large Chromosomal Rearrangements Yield Biomarkers to Distinguish Low-Risk From Intermediate- and High-Risk Prostate Cancer. Mayo Clinic Proceedings. 94(1). 27–36. 7 indexed citations
7.
Bryce, Alan H., Jan B. Egan, James B. Smadbeck, et al.. (2019). Shared and unique genomic structural variants of different histological components within testicular germ cell tumours identified with mate pair sequencing. Scientific Reports. 9(1). 3586–3586. 5 indexed citations
8.
Vasmatzis, George, Xue Wang, James B. Smadbeck, et al.. (2018). Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples. BMC Cancer. 18(1). 738–738. 14 indexed citations
9.
Liu, Yang, Phuong Le, Sung Jun Lim, et al.. (2018). Enhanced mRNA FISH with compact quantum dots. Nature Communications. 9(1). 4461–4461. 39 indexed citations
10.
Murphy, Stephen J., Farhad Kosari, R. Jeffrey Karnes, et al.. (2017). Retention of Interstitial Genes between TMPRSS2 and ERG Is Associated with Low-Risk Prostate Cancer. Cancer Research. 77(22). 6157–6167. 5 indexed citations
11.
Johnson, Sarah H., James B. Smadbeck, Stephanie A. Smoley, et al.. (2017). SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq). Cancer Genetics. 221. 1–18. 61 indexed citations
12.
Mansfield, Aaron S., Stephen J. Murphy, Faye R. Harris, et al.. (2016). Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib. Annals of Oncology. 27(11). 2111–2117. 56 indexed citations
13.
Murphy, Stephen J., Steven N. Hart, Geoffrey C. Halling, et al.. (2015). Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease. Cancer Research. 76(3). 749–761. 25 indexed citations
14.
Mansfield, Aaron S., Stephen J. Murphy, Tobias Peikert, et al.. (2015). Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer. Clinical Cancer Research. 22(9). 2177–2182. 105 indexed citations
15.
Schaefer-Klein, Janet, Stephen J. Murphy, Sarah H. Johnson, George Vasmatzis, & Irina V. Kovtun. (2015). Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression. PLoS ONE. 10(11). e0142327–e0142327. 44 indexed citations
16.
Graham, Rondell P., Emily G. Barr Fritcher, Ekaterina Pestova, et al.. (2014). Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Human Pathology. 45(8). 1630–1638. 227 indexed citations
17.
Murphy, Stephen J., et al.. (2007). A Unique Element in the Cytoplasmic Tail of the Type II Transforming Growth Factor-β Receptor Controls Basolateral Delivery. Molecular Biology of the Cell. 18(10). 3788–3799. 22 indexed citations
18.
Murphy, Stephen J. & William H. Frishman. (2005). Protein Kinase C in Cardiac Disease and as a Potential Therapeutic Target. Cardiology in Review. 13(1). 3–12. 42 indexed citations
19.
Wilkes, Mark C., Stephen J. Murphy, Nandor Garamszegi, & Edward B. Leof. (2003). Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3. Molecular and Cellular Biology. 23(23). 8878–8889. 115 indexed citations
20.
Ahmed, Atique U., Jill Thompson, Stephen J. Murphy, et al.. (2003). A conditionally replicating adenovirus targeted to tumor cells through activated RAS/P-MAPK-selective mRNA stabilization. Nature Biotechnology. 21(7). 771–777. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026